{
    "clinical_study": {
        "@rank": "41844", 
        "acronym": "D5630C00001", 
        "arm_group": [
            {
                "arm_group_label": "controlled arm", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "treatment arm", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This clinical trial is an international, multicenter, randomized, double-blind,\n      placebo-controlled, parallel-group trial comparing one dose of linaclotide to placebo.\n      Approximately 800 patients with a diagnosis of IBS-C (modified Rome III criteria) will be\n      randomized at up to 60 trial centers in China, Australia, and New Zealand.\n\n      The trial will consist of up to 21 days of screening, 14 to 21 days of pre-treatment, 12\n      weeks of double-blind treatment, and 2 weeks of follow-up. At the end of the Pre-treatment\n      Period, patients meeting the entry criteria for this trial will be randomized to one of two\n      double-blind treatment groups: 290 ug linaclotide, or placebo (1:1)."
        }, 
        "brief_title": "A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Irritable Bowel Syndrome With Constipation (IBS-C)", 
        "condition_browse": {
            "mesh_term": [
                "Constipation", 
                "Irritable Bowel Syndrome"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patient has signed an Informed Consent Form(ICF).\n\n          2. Patient Must not be pregnant or breastfeeding and agree to use birth control\n\n          3. Patient meets the colonoscopy requirements defined by the American\n             Gastroenterological Association guidelines and no clinically-significant laboratory\n             or physical examination findings;\n\n          4. Patient meets protocol-defined criteria for Irritable Bowel Syndrome with\n             Constipation(IBS-C), including stool frequency, straining, stool consistency,\n             abdominal pain, and abdominal discomfort criteria\n\n          5. Patient meets protocol-defined eDiary completion Compliance and agrees to refrain\n             from making any new, major life-style changes that may affect IBS-C symptoms\n\n        Exclusion Criteria:\n\n          1. Recent history of mushy or watery stools\n\n          2. Various medical conditions, medical histories, or family medical histories that would\n             not make the patient a good candidate for the study\n\n          3. Patient currently has both unexplained and clinically significant alarm symptoms or\n             systemic signs of infection or colitis.\n\n          4. Surgery to the gastrointestinal tract\n\n          5. Usage of prohibited medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01880424", 
            "org_study_id": "ICP-103-307"
        }, 
        "intervention": [
            {
                "arm_group_label": "controlled arm", 
                "description": "matching Placebo Capsules, Oral, once daily", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "treatment arm", 
                "description": "Linaclotide 290 ug Capsules, Oral, once daily", 
                "intervention_name": "Linaclotide", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 23, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bedford Park", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Box Hill", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Callaghan", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Five Dock", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Malvern", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maroubra", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Melbourne", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parkville", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sydney", 
                        "country": "Australia"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changsha", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harerbin", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hefei", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nanchang", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Qingdao", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shijiazhuang", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xi'An", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Xiamen", 
                        "country": "China"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Auckland", 
                        "country": "New Zealand"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Christchurch", 
                        "country": "New Zealand"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dunedin", 
                        "country": "New Zealand"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wellington", 
                        "country": "New Zealand"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Australia", 
                "China", 
                "New Zealand"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)", 
        "overall_contact": {
            "last_name": "Lennie Wu, Master", 
            "phone": "86-2038183761"
        }, 
        "overall_official": [
            {
                "affiliation": "Chinese People's Liberation Army General Hospital", 
                "last_name": "Yunsheng Yang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Beijing Friendship Hospital", 
                "last_name": "Shutian Zhang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Changhai Hospital Affiliated to Second Military Mecical University of Chinese PLA", 
                "last_name": "Zhaoshen Li", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Changzheng Hospital Affiliated to Second Military Mecical University of Chinese PLA", 
                "last_name": "Weifen Xie", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University", 
                "last_name": "Yaozong Yuan", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Beijing Tiantan Hospital", 
                "last_name": "Youqing Xu", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Third Affiliated Hospital of Third Military Mecical University of Chinese PLA", 
                "last_name": "Dongfeng Chen", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The First Affiliated Hospital, Zhongshan (Sun Yat-sen) University", 
                "last_name": "Minhu Chen", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Qilu Hospital", 
                "last_name": "Yanqing Li", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "General Hospital of Shenyang Military Region of Chinese PLA", 
                "last_name": "Xiaozhong Guo", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "First Affiliated Hospital of Harbin Medical University", 
                "last_name": "Youlin Yang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The First Affiliated Hospital of Third Military Mecical University of Chinese PLA", 
                "last_name": "Rongquan Wang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Union Hospital of Tongji Medical College of Huazhong University of Science & Technology", 
                "last_name": "Xiaohua Hou", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Sichuang Provincial People's Hospital", 
                "last_name": "Liangping Li", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "West China Hospital", 
                "last_name": "Chengwei Tang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Zhongshan Hospital Affiliated to Xiamen University", 
                "last_name": "Jianlin Ren", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Zhongshan Hospital Affiliated to Fudan University", 
                "last_name": "Xizhong Shen", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Peking University People's Hospital", 
                "last_name": "Yulan Liu", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Beijing Tongren Hospital Affiliated to Capital Medical University", 
                "last_name": "Dongmei Qian", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Peking University First Hospital", 
                "last_name": "Huahong Wang", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "China: Food and Drug Administration", 
                "Australia: Therapeutic Goods Administration (TGA)", 
                "New Zealand: Ministry of Health, Medsafe"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "A 12-week Abdominal Pain/Abdominal Discomfort Responder is a patient who meets the Abdominal Pain/Abdominal Discomfort Weekly Responder criteria for at least 6 out of the first 12 weeks of the Treatment Period.", 
                "measure": "Abdominal Pain/Abdominal Discomfort Weekly Responder rate", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "A 12-week IBS Degree of Relief Responder is a patient who meets the IBS Degree of Relief Weekly Responder criteria for at least 6 out of the 12 weeks of the Treatment Period.", 
                "measure": "Irritable Bowel Syndrome (IBS) Degree of Relief Responder rate", 
                "safety_issue": "No", 
                "time_frame": "12weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01880424"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from Baseline in 12-week Complete Spontaneous Bowel Movement Frequency Rate", 
                "safety_issue": "No", 
                "time_frame": "12weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Spontaneous Bowel Movement Frequency Rate", 
                "safety_issue": "No", 
                "time_frame": "12weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Stool Consistency", 
                "safety_issue": "No", 
                "time_frame": "12weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Severity of Straining", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Abdominal Bloating", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Abdominal Pain", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Change from Baseline in 12-week Abdominal Discomfort", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "collaborator": {
                "agency": "Ironwood Pharmaceuticals, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}